Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
127,672,444
-
Total 13F shares
-
64,995,349
-
Share change
-
+985,314
-
Total reported value
-
$2,795,313,666
-
Put/Call ratio
-
40%
-
Price per share
-
$42.91
-
Number of holders
-
171
-
Value change
-
+$19,912,057
-
Number of buys
-
78
-
Number of sells
-
79
Institutional Holders of Apellis Pharmaceuticals, Inc. - Common Stock (APLS) as of Q1 2021
As of 31 Mar 2021 Apellis Pharmaceuticals, Inc. - Common Stock (APLS) had 171 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 64,995,349 shares of stock of the company.
Largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., HILLHOUSE CAPITAL ADVISORS, LTD., PRICE T ROWE ASSOCIATES INC /MD/, JENNISON ASSOCIATES LLC, STATE STREET CORP, Farallon Capital Management, L.L.C., VICTORY CAPITAL MANAGEMENT INC, and Cormorant Asset Management, LP.
This table shows 172 institutional shareholders of the security as of 31 Mar 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.